Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.
Deepak Kilari(Medical College of Wisconsin), Adam James Robin(Medical College of Wisconsin), Kenneth A. Iczkowski(University of California, Davis), Edward M. Messing(University of Rochester Medical Center), Elizabeth A. Guancial(Harvard University), Chintan Pandya(University of Rochester)
PubMed
February 1, 2016
Cited by 44
Related Papers
Classification of renal cell carcinoma
|Cancer|1997|878
The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
|New England Journal of Medicine|2006|873
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487